Søren Bøgestrand

Søren Bøgestrand is currently a Regulatory Affairs Principal at Ambu A/S, having held that position since 2022. Previously, they served as a Regulatory Affairs Specialist at Novo Nordisk from 2020 to 2021 and held multiple roles at Radiometer Medical, including Principal Specialist in Regulatory Affairs from 2018 to 2020. Søren began their career as a Biochemist at ALK-Abelló A/S from 1994 to 2000, followed by a role as a Scientific Officer at the Danish Medicines Agency from 2000 to 2008. They hold an M.Sc. in Chemistry and Biochemistry from Aarhus University, earned in 1994.